Last reviewed · How we verify

NCT03753607

Renal Venous Flow and Cardiac Surgery-associated Acute Kidney Injury

Completed Last updated 1 December 2023
What this trial tests

trial testing No intervention in Acute Kidney Injury in 200 participants. Completed in 24 November 2023.

Timeline
20 December 2018
Primary endpoint
14 January 2022
24 November 2023

Quick facts

Lead sponsorUniversity of Giessen
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date20 December 2018
Primary completion14 January 2022
Estimated completion24 November 2023
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Giessen

Who can join

18 and older, any sex, with Acute Kidney Injury or Cardiorenal Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The prospective single-center study investigates the association between changes in Doppler-derived renal venous flow and cardiac surgery-associated acute kidney injury (CSA-AKI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Acute Kidney Injury

Currently open trials in the same condition.

Other University of Giessen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03753607.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing